IL265217B2
Glucocorticoid receptor modulators to treat pancreatic cancer
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2007281928A1 | Cites | United States of America | Y | Search report | 1-21 |
| WO2013177559A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-21 |
| WO2015077530A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-21 |
| WO2016055533A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-21 |
45 members in 14 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662385590 | United States of America | P | |
| 2017050812 | United States of America | W |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| CA3034114A1 | Canada | A1 | |
| US2018071255A1 | United States of America | A1 | |
| WO2018049255A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US9943505B2 | United States of America | B2 | |
| US2018193313A1 | United States of America | A1 | |
| US10117852B2 | United States of America | B2 | |
| US2019030001A1 | United States of America | A1 | |
| ZA201901135A0 | South Africa | A0 | |
| US10213414B2 | United States of America | B2 | |
| AU2017323636A1 | Australia | A1 | |
| KR20190040511A | Republic of Korea | A | |
| CN109689044A | China | A | |
| US2019151288A1 | United States of America | A1 | |
| BR112019004322A2 | Brazil | A2 | |
| IL265217A | Israel | A | |
| IL265217D0 | Israel | D0 | |
| EP3509584A1 | European Patent Office (EPO) | A1 | |
| PH12019500475A1 | Philippines | A1 | |
| MX2019002703A | Mexico | A | |
| US10449178B2 | United States of America | B2 | |
| JP2019530666A | Japan | A | |
| US2020000771A1 | United States of America | A1 | |
| AU2017323636B2 | Australia | B2 | |
| EP3509584A4 | European Patent Office (EPO) | A4 | |
| US10646474B2 | United States of America | B2 | |
| US2020230107A1 | United States of America | A1 | |
| ZA201901135B | South Africa | B | |
| US10828280B2 | United States of America | B2 | |
| US2021030717A1 | United States of America | A1 | |
| JP2021050242A | Japan | A | |
| CN109689044B | China | B | |
| CA3034114C | Canada | C | |
| JP7003117B2 | Japan | B2 | |
| MX2022001583A | Mexico | A | |
| JP2022105213A | Japan | A | |
| KR102424221B1 | Republic of Korea | B1 | |
| JP7174083B2 | Japan | B2 | |
| IL265217B | Israel | B | |
| IL265217B2This record | Israel | B2 | |
| US11642331B2 | United States of America | B2 | |
| US2023285361A1 | United States of America | A1 | |
| MX393500B | Mexico | B | |
| NZ750756A | New Zealand | A | |
| US12370175B2 | United States of America | B2 | |
| US2025312312A1 | United States of America | A1 |
Numbers
- Publication
- 265217
- Application
- 26521719
Titles2
- English
- Glucocorticoid receptor modulators to treat pancreatic cancer
- Hebrew
- מודולטורים של קולטנים גלוקוקורטיקואידים ושימוש בהם לטיפול בסרטן לבלב
Classification
- CPC, 15
- A61K31/337
- A61K33/243
- A61K31/416
- A61K45/06
- A61K31/513
- A61K31/7068
- A61K31/473
- A61P1/18
- A61P35/00
- A61P43/00
- A61K31/4192
- A61K31/44
- A61K31/4745
- A61K31/18
- A61K31/03
- IPC, 14
- A61K31 03
- A61K31 18
- A61K31 337
- A61K31 416
- A61K31 4192
- A61K31 44
- A61K31 473
- A61K31 4745
- A61K31 513
- A61K31 7068
- A61K33 243
- A61K45 06
- A61P35 00
- A61P43 00